Susan Hasty, Publisher
Table of Contents . . . May 16th, 2000
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Cancer Weekly | Other Publications
Renal Cell Cancer - Randomized Phase II Trial Compares Combination Vaccine Therapy
Cancer Immunotherapy - Phage-Selected Primate Antibodies Fused to Superantigens Used to Treat Melanoma
Epstein-Barr Virus - Viral DNA a Marker for Nasopharyngeal Cancer
Head and Neck Cancer - Attenuated Virus Studied as Cancer Treatment in Phase I Trial
Hepatocellular Carcinoma - Hypermethylation at Gene Site is Possible Cause of Liver Pathogenesis
Kidney Transplantation - p53 Codon 72 Variant Not Associated with Post-Transplant Skin Cancer
Leukemia - Low Doses of Interleukin-4, Amifostine Can Reduce Leukemia Cell Factors
Lipomas - 'Obesity Gene' Causes Cancer of Fat Tissue
Liver Cancer - Vinyl Chloride Exposure Changes p53 Gene Structure
Lymphoma - Monoclonal Antibodies Recognizing CD5, CD10, and CD23 Aid Diagnosis
Melanoma - Mutation in the 5' UTR May Increase Susceptibility
Anti-Angiogenesis - Col-3 May be Useful in Intracranial Tumor Treatment
Anti-Angiogenesis - Endostatin May Aid Against Glioblastomas
Cancer Gene Therapy - Epithelial Ovarian-Cancer-Specific Promoter Helps Target Gene Therapy
Cancer Therapies - Monoclonal Antibody/Fusion Protein Eradicates erbB-2 Positive Tumors
Cancer Therapy - 'Stealth Compounds' Attack Cancer Cells
Cancer Vaccines - Antibody-Dependent Cellular Cytotoxicity Induced by MUC1 Peptide Vaccine
Content/Internet Health - Aetna U.S. Healthcare's InteliHealth Allies with Harvard, Johns Hopkins Dropped
Melanoma - Misdiagnosis of Skin Cancer Can Be Fatal
Melanoma - Peptide-Pulsed Dendritic Cells Induce Immune Response Against Skin Cancer
Melanoma - Protecting Children from Skin Cancer
Ovarian Cancer - Variables Identified as Predictors of Poor Adherence to Surveillance Recommendations
Renal Cell Carcinoma - Dendritic Cell Vaccines Evaluated
Industry News - Collaboration Tests New Cancer Treatments
Medical Marijuana - Hawaii Senate OKs Marijuana Bill
Ovarian Cancer - FDA Approval Received for Hyperthermia + Chemotherapy Study
Patent News - Human Papillomavirus Type 68A Patent Exclusively Licensed
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.